a | ||||||||
 | Grade 0 | Grade 1 | Grade 2 | Grade 3 | Grade 4 | |||
TRG | 1 | 14 | 45 | 50 | 19 | |||
Acute toxicity | ||||||||
 Skin | 50 | 50 | 22 | 10 | 0 | |||
 Bladder | 63 | 55 | 9 | 4 | 1 | |||
 Rectum | 18 | 65 | 31 | 16 | 2 | |||
 Small bowel | 51 | 54 | 18 | 5 | 4 | |||
Late toxicity | ||||||||
 Skin | 110 | 16 | 0 | 0 | 0 | |||
 Bladder | 105 | 4 | 2 | 14 | 1 | |||
 Rectum | 88 | 12 | 19 | 2 | 5 | |||
b | ||||||||
 | MN/BNL | NPB/BNL | ||||||
 | 3Gy in vitro | End RCT (50.4Gy) | 3 Gy in vitro | End RCT (50.4Gy) | ||||
 | Kendall’s τ [CI] | P | Kendall’s τ [CI] | P | Kendall’s τ [CI] | P | Kendall’s τ [CI] | P |
TRG | 0.09 [−0.04–0.19] | 0.18 | −0.02 [−0.13–0.10] | 0.78 | −0.06 [−0.16–0.07] | 0.42 | −0.12 [−0.21–0.02] | 0.09 |
Acute toxicity | ||||||||
 Skin | 0.10 [−0.01–0.18] | 0.13 | 0.04 [−0.08–0.14] | 0.56 | 0.00 [− 0.12–0.12] | 1.00 | − 0.09 [− 0.18–0.04] | 0.21 |
 Bladder | − 0.01 [− 0.11–0.10] | 0.88 | 0.06 [− 0.06–0.16] | 0.36 | 0.09 [− 0.04–0.18] | 0.21 | 0.04 [− 0.08–0.13] | 0.61 |
 Rectum | 0.13 [0.00–0.21] | 0.06 | 0.02 [− 0.11–0.14] | 0.82 | − 0.17 [− 0.25 - -0.02] | 0.01 | − 0.10 [− 0.20–0.03] | 0.15 |
 Small bowel | −0.07 [− 0.17–0.05] | 0.28 | 0.02 [− 0.10–0.13] | 0.77 | 0.04 [− 0.07–0.14] | 0.56 | 0.09 [− 0.04–0.18] | 0.21 |
Late toxicity | 0.07 [− 0.06–0.17] | 0.30 | −0.03 [− 0.15–0.10] | 0.67 | −0.07 [− 0.16–0.06] | 0.33 | −0.04 [− 0.14–0.08] | 0.61 |
 Skin | 0.00 [− 0.08–0.08] | 1.00 | −0.12 [− 0.13–0.01] | 0.11 | 0.02 [− 0.07–0.09] | 0.75 | 0.03 [− 0.06–0.09] | 0.72 |
 Bladder | −0.03 [− 0.10–0.07] | 0.73 | 0.01 [− 0.09–0.10] | 0.89 | −0.10 [− 0.014–0.03] | 0.17 | −0.03 [− 0–09 - 0.06] | 0.68 |
 Rectum | 0.06 [− 0.06–0.14] | 0.40 | −0.10 [− 0.17–0.03] | 0.18 | 0.04 [− 0.07–0.12] | 0.57 | 0.02 [− 0.09–0.11] | 0.83 |